TTNP

Titan Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 1.7% 2.39 11:21:31
Open Price Low Price High Price Close Price Prev Close
2.31 2.256 2.44 2.35
more quote information »

Recent News

Date Time Source Heading
4/20/20211:51IHNWFeaturedLegion Capital to Accept Bitcoin and Ethereum for Investments on GoLegion
4/20/20211:55IHNWFeaturedRelay Medical and Fio Partner with LifeLabs, Canadian Healthcare Leader, to Deploy Fionet Platform for COVID-19 Testing...
4/21/20216:00IHNWFeaturedNeoVolta's New Patent-Pending Technology Provides an Additional Power Option During Grid Outages
4/21/20216:25IHNWFeaturedEpazz, Inc. (OTC Pink: EPAZ) Cryptocurrency App Bitcoin Wallet 10,000+ Downloads
3/31/202116:30PRNUSTitan Pharmaceuticals Announces Filing Of 2020 Annual Report..
3/31/202116:08EDGARAnnual Report (10-k)
2/11/202106:38EDGARStatement of Changes in Beneficial Ownership (4)
2/11/202106:32EDGARStatement of Changes in Beneficial Ownership (4)
2/11/202106:27EDGARStatement of Changes in Beneficial Ownership (4)
2/08/202106:05EDGARNotice of Effectiveness (effect)
2/04/202114:25EDGARCurrent Report Filing (8-k)
2/04/202106:11EDGARSecurities Registration Statement (s-1/a)
2/01/202107:30PRNUSPositive Early Study Results Help Pave Wave for Titan..
1/25/202108:26EDGARStatement of Ownership (sc 13g)
1/22/202111:59EDGARStatement of Ownership (sc 13g)
1/21/202114:29EDGARStatement of Ownership (sc 13g)
1/19/202106:22EDGARCurrent Report Filing (8-k)
1/19/202106:12EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/15/202109:15PRNUSTitan Pharmaceuticals Announces Pricing of $9.7 Million..
1/08/202116:16EDGARCurrent Report Filing (8-k)
1/07/202110:01EDGARAmended Statement of Ownership (sc 13g/a)
12/31/202006:01EDGARCurrent Report Filing (8-k)
12/31/202006:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/17/202006:02EDGARCurrent Report Filing (8-k)
12/16/202008:00PRNUSTitan Pharmaceuticals Regains Compliance with Nasdaq Listing..
12/16/202006:04EDGARNotice of Effectiveness (effect)
12/08/202006:02EDGARSecurities Registration Statement (s-1)
12/03/202016:24EDGARCurrent Report Filing (8-k)
12/02/202016:59EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/30/202012:50PRNUSTitan Pharmaceuticals Announces Reverse Stock Split
11/25/202008:29EDGARProxy Statement (definitive) (def 14a)
11/16/202008:45PRNUSTitan Pharmaceuticals Reports Third Quarter 2020 Financial..
11/09/202014:32EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/09/202006:06EDGARStatement of Ownership (sc 13g)
11/02/202016:14EDGARCurrent Report Filing (8-k)
11/02/202016:08EDGARProxy Statement (definitive) (def 14a)
11/02/202008:00PRNUSTitan Pharmaceuticals Completes Debt Settlement With Molteni..
10/29/202017:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/29/202006:06EDGARNotice of Effectiveness (effect)
10/28/202016:47EDGARCurrent Report Filing (8-k)
10/28/202015:00PRNUSTitan Pharmaceuticals Announces Pricing of $8.0 Million..
10/28/202008:00PRNUSTitan Pharmaceuticals Enters Into Definitive Agreement To..
10/27/202016:12EDGARSecurities Registration Statement (s-1/a)
10/26/202006:41EDGARSecurities Registration Statement (s-1/a)
10/26/202006:36EDGARCurrent Report Filing (8-k)
10/26/202006:30PRNUSTitan Pharmaceuticals Announces Debt Settlement Agreement..
10/23/202017:08EDGARProxy Statement - Notice of Shareholders Meeting..
10/15/202015:56EDGARCurrent Report Filing (8-k)
10/15/202008:00PRNUSTitan Pharmaceuticals Provides a Strategic & Corporate..
10/01/202016:42EDGARStatement of Ownership (sc 13g)
9/25/202006:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/25/202006:01EDGARCurrent Report Filing (8-k)
9/24/202009:00PRNUSTitan Pharmaceuticals Announces Pricing of $2.7 Million..
9/18/202016:45PRNUSTitan Pharmaceuticals' Stockholders Approve Proposal To..
See more news about this stock »


Your Recent History
NASDAQ
TTNP
Titan Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.